LLY vs ISRG
Eli Lilly · Intuitive Surgical
| LLY Eli Lilly Healthcare | ISRG Intuitive Surgical Healthcare | |
|---|---|---|
| Market | ||
| Price | $1,417.54 +3.19% | $432.01 -3.73% |
| Market cap | $1.33T | $149.8B |
| P/E (TTM) | 48.4 | 50.6 |
| Dividend yield | 0.75% | — |
| 52-week range | $809.63 – $1,408.38 | $328.57 – $603.88 |
| Our research | ||
| Our view | LONG open | LONG open |
| Articles | 1 | 1 |
| Latest article | Eli Lilly (LLY): Two Drugs Drove 88% Of Growth, EPS Hit By $4.57 R&D Oct 31, 2026 | Intuitive Surgical (ISRG): Non-GAAP EPS Up 25%, GAAP EPS Down 24%, And A $450M Settlement… Nov 1, 2026 |
| Latest earnings | ||
| Reported | Oct 29, 2026 | Oct 20, 2026 |
| Revenue | $24.4 billion +39% YoY | $3.05 billion +22% YoY |
| EPS | $7.22 +7% YoY | $0.99 |
| Guidance | Guidance raised | Guidance issued |
| Revenue growth, last 4 reports | +39% +48% | +22% |
| Topics | ||
| Main topics | ||
| Company page · Earnings releases | Company page · Earnings releases | |
Shared topics: Earnings Quality
Note. Earnings figures are extracted automatically from each company's own release; prices are delayed up to 15 minutes. This comparison is information, not investment advice.